Materialized View Selection for Multidimensional Datasets

Abstract

Echocardiography is widely available in most cardiac centers, plays a key role in both the diagnosis and management of IE, is often the first-hand imaging modality, and should be performed immediately when mitral regurgitation is suspected. In addition, it is helpful during therapy and after surgery to assess valve morphology and function, complications, and heart function. In particular, transthoracic echocardiography is useful to detect new silent complications, monitor vegetation size, assess perivalvular abscess formation, pseudoaneurysm, intracardiac fistula and valvular perforation, as well as examine the embolic risk. In addition, echocardiographic outcomes differences among cardiovascular outcomes assessment of the MitraClip percutaneous therapy for heart failure patients with functional mitral regurgitation (COAPT) like and non COAPT-like patients have shown that non COAPT-like patients had higher left ventricular (LV) dimensions and overall contractility therefore, differences in clinical outcomes have been underestimated. Mitral transcatheter edge-to-edge repair (MTEER) is an established therapeutic approach for mitral regurgitation (MR). Recurrence of MR after TEER with MitraClip is a concern due to increased patients' hospital readmission rate and increasing hospital costs. However, little is known about clinical, valvular, or ventricular parameters that may impact postinterventional course and recurrence of MR after TEER. While individual long-term echocardiographic outcomes of functional vs degenerative MR have been described, there is little data on follow-up echocardiographic outcomes comparing functional vs degenerative MR.